News & Events

Our webinar highlights the need of reliable prognostic tests to personalise long COVID patients’ pathways

On 2 March 2023, COVIRNA hosted the webinar 'Patient-centred approaches to long COVID'. Moderated by Mr George Valiotis, Executive Director at EHMA, this webinar focused on overcoming the challenges posed by long COVID. Dr Tomas Zapata, Programme Manager in the Division of Country Health Policies...

Read More

Join our final conference ‘Improving personalised care and patient outcomes through molecular diagnostics and therapy’

At the dawn of the pandemic, the European Commission earmarked a large envelop to develop rapid health-related approaches to respond to the COVID-19 pandemic and to deliver quick results for society for a higher level of preparedness of health systems including medical supplies, equipment, techno...

Read More

Patient-centred approaches to long COVID – Join our upcoming webinar

In the WHO European Region, it is estimated that at least 17 million individuals may have experienced long COVID in 2020 and 2021[1]. Long COVID is characterised by the persistence of COVID-19 symptoms beyond 3 months and is causing both personal suffering and significant burden on health systems...

Read More

The report of our recent webinar on unmet clinical needs is out!

On 5 January 2023, together with the EU-funded projects ENVISION and COVend, we held a joint webinar on ’Addressing unmet clinical needs, practices and patient outcomes: the impact of EU-funded projects'. Experts addressed achievements and challenges regarding the impact of EU-funded projects on ...

Read More

Addressing unmet clinical needs, practices and patient outcomes: the impact of EU-funded projects. A joint webinar by the COVIRNA, ENVISION and COVend projects

Agenda Register A large number of public-funded projects at the EU, national or regional level aims to address unmet clinical needs and improve clinical practices as well as patient outcomes by developing diagnostic/ prognostic tools or advanced therapies. Investigators of three of these EU ...

Read More

The COVIRNA project was presented at the ‘Back to a Healthy Future’ event 

On 21 - 22 September, the Back to a Healthy Future event took place in Brussels. This technological showcase brought together companies and organisations from several European countries willing to respond rapidly to urgent needs in the healthcare system. The particular focus was on solutions to i...

Read More
EHMA 2022 session hosted by COVIRNA

The COVIRNA session at EHMA 2022 highlights the potential of innovative diagnostic tools

On Friday, 17 June, the COVIRNA project hosted a session at the EHMA 2022 Annual Conference titled ‘The potential of innovative diagnostic tools: personalised disease management for improved health outcomes in COVID-19 patients’. The session looked at the impact and benefits of the adoption of no...

Read More
COVIRNA project at the EHMA 2022 Annual Conference

The COVIRNA project to host a session at the EHMA 2022 Annual Conference

The COVIRNA project will be participating in the EHMA 2022 Annual Conference with the session ‘The potential of innovative diagnostic tools: personalised disease management for improved health outcomes in COVID-19 patients’, on Friday, 17 June at 11:15 AM CET. EHMA 2022 Annual Conference&nbs...

Read More
COVIRNA project featured at European events on cardiovascular medicine

COVIRNA featured at the European events on cardiovascular medicine

In April, the COVIRNA project was featured at three European events focused on cardiovascular medicine. Dr Yvan Devaux, the COVIRNA Project Coordinator, represented the project at the final EU-CARDIOPROTECTION COST Action meeting on 2-4 April in Coimbra (Portugal), 2nd Olympiad in Cardiovascular ...

Read More
lncRNA Biomarker of cardiovascular disease

lncRNA: Biomarker for diagnosing and prognosing cardiovascular diseases

Cardiovascular diseases (CVDs) are the leading cause of death globally. According to the World Health Organisation, an estimated 17.9 million people die each year from CVDs. This represents 32% of all global deaths. CVDs are responsible for twice as many death as cancer in both men and women.&nbs...

Read More